SB 465-FN - AS ~~INTRODUCED~~ SESSION 26-2002 09/05 SENATE BILL 465-FN AN ACT classifying xylazine as a schedule III controlled drug.

SB 465-FN - AS AMENDED BY THE SENATE 03/05/2026 0842s SESSION 26-2002 09/05 SENATE BILL 465-FN AN ACT classifying xylazine as a schedule III controlled drug.

SB 465-FN - AS ~~INTRODUCED~~ 26-2002 09/05 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT classifying xylazine as a schedule III controlled drug.

SB 465-FN - AS AMENDED BY THE SENATE 03/05/2026 0842s 26-2002 09/05 STATE OF NEW HAMPSHIRE In the Year of Our Lord Two Thousand Twenty-Six AN ACT classifying xylazine as a schedule III controlled drug.

I.

II.

Notwithstanding paragraph I, nothing in this section shall prevent any licensed veterinarian, as defined in RSA 332-B:1, from doing any of the following:

(a) Dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the Secretary of Health and Human Services under section 512 of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.

section 360b.

(b) Dispensing or prescribing for, or administering to, a nonhuman species that is permissible under section 512(a)(4) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.

section 360b(a)(4).

(c) Another use that is approved or permissible under the Federal Food, Drug, and Cosmetic Act.

LBA 26-2002 ~~11/16/25~~ SB 465-FN- FISCAL NOTE AS ~~INTRODUCED~~ AN ACT classifying xylazine as a schedule III controlled drug.

LBA 26-2002 04/06/2026 SB 465-FN- FISCAL NOTE AS AMENDED BY THE SENATE (AMENDMENT #2026-0842s) AN ACT classifying xylazine as a schedule III controlled drug.